# Artificial Intelligence-Enhanced Management for Coronary Heart Disease (AIM-CHD) : Impact on Cholesterol and Other CHD Risk Factors

> **NCT06686056** · NA · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 1100 (actual)

## Conditions studied

- Secondary Prevention of Coronary Heart Disease

## Interventions

- **COMBINATION_PRODUCT:** AIM-CHD Mobile Health Intervention
- **COMBINATION_PRODUCT:** Usual post-discharge care

## Key facts

- **NCT ID:** NCT06686056
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-23
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686056, "Artificial Intelligence-Enhanced Management for Coronary Heart Disease (AIM-CHD) : Impact on Cholesterol and Other CHD Risk Factors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06686056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*